Cencora | COR - Cash And Equivalent


Cencora reported $2.18B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Ambu A/S DKK 691M 44M Mar/2026
Amplifon EUR 309.56M 673K Mar/2026
Apollo Hospitals Enterprise Ltd INR 13.6B 8.5B Mar/2025
Avanos Medical USD 65.6M 24.2M Mar/2026
Brookdale Senior Living USD 265.2M 13.92M Mar/2026
Cencora USD 2.18B 423.37M Mar/2026
Coloplast 911M 497M Sep/2023
Convatec Group USD 64.7M 32.2M Dec/2024
Diasorin EUR 173.08M 3.51M Jun/2025
Encompass Health USD 110.5M 38.3M Mar/2026
Enovis USD 33.13M 3.26M Mar/2026
GE HealthCare Technologies USD 2.26B 2.23B Mar/2026
Gulf Medical Proj AED 74.52M 101.52M Mar/2025
Hoya 596.39B 62.76B Sep/2025
Med Life RON 185.35M 35.79M Sep/2025
Oriola-kd EUR 107.6M 13.9M Sep/2025
Pediatrix Medical Group USD 205.78M 169.46M Mar/2026
Rede D'or Sao Luiz BRL 5.41B 1.7B Mar/2026
Siemens Healthineers EUR 2.14B 231M Dec/2025
Solventum Corp USD 561M 317M Mar/2026
Sonova Holding CHF 413.9M 134.3M Jun/2023
Supermax Corporation Bhd MYR 637.59M 217.66M Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026